Sheryl Ann Lisowski - Nov 10, 2023 Form 4 Insider Report for FASTENAL CO (FAST)

Role
CAO/CONTROLLER/TREASURER
Signature
/s/ John J. Milek , Attorney-in-Fact
Stock symbol
FAST
Transactions as of
Nov 10, 2023
Transactions value $
-$587,994
Form type
4
Date filed
11/13/2023, 05:33 PM
Previous filing
Jan 23, 2023
Next filing
Jan 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FAST Common Stock Options Exercise $90K +3.83K +75.12% $23.50 8.92K Nov 10, 2023 Direct
transaction FAST Common Stock Sale -$230K -3.83K -42.9% $60.00 5.1K Nov 10, 2023 Direct
transaction FAST Common Stock Options Exercise $180K +6.55K +128.45% $27.50 11.6K Nov 10, 2023 Direct
transaction FAST Common Stock Sale -$393K -6.55K -56.23% $60.01 5.1K Nov 10, 2023 Direct
transaction FAST Common Stock Options Exercise $180K +6.92K +135.83% $26.00 12K Nov 10, 2023 Direct
transaction FAST Common Stock Sale -$415K -6.92K -57.6% $60.01 5.1K Nov 10, 2023 Direct
holding FAST Common Stock 2.01K Nov 10, 2023 Held in 401(K) Plan F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FAST Employee Stock Option (Right to Buy) Options Exercise $0 -3.83K -100% $0.00* 0 Nov 10, 2023 Common Stock 3.83K $23.50 Direct F2
transaction FAST Employee Stock Option (Right to Buy) Options Exercise $0 -6.55K -100% $0.00* 0 Nov 10, 2023 Common Stock 6.55K $27.50 Direct F3
transaction FAST Employee Stock Option (Right to Buy) Options Exercise $0 -6.92K -66.66% $0.00 3.46K Nov 10, 2023 Common Stock 6.92K $26.00 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares attributed to reporting person's account within issuer's 401(K) Plan and includes an additional 61 shares acquired since the reporting person's prior report filed on 7/18/2022.
F2 The option will fully vest and become exercisable over a period of five years, with 40% of the option vesting and becoming exercisable halfway through the relevant vesting period and the remainder vesting and becoming exercisable proportionately (20%) each year thereafter.
F3 The option will vest and become exercisable over a period of five years, with 50% of the option vesting and becoming exercisable two years following the date of grant and the remainder vesting and becoming exercisable proportionately (20%) each year thereafter.